"The number of customers using our PCT platform in the workflow for mass spectrometry has increased dramatically in the last year, and so we're addressing that market particularly," said PBI's CEO.
The company will be working to improve methods of biomolecule extraction to allow researchers to better use archival formalin-fixed, paraffin-embedded tissue samples in studies of disease progression and response to therapy.
The CRADA with Armed Forces Institute of Pathology, the American Registry of Pathology, and the Department of Veterans Affairs is to develop pressure-based sample prep methods to improve the quality and yield of biomolecular extractions from FFPE tissue.
